Table 2.

Other Genes of Interest in the Differential Diagnosis of Li-Fraumeni Syndrome

Gene(s)DisorderMOICore Cancer(s)Age at Cancer OnsetComments
BRCA1
BRCA2
BRCA1- and BRCA2-associated hereditary breast and ovarian cancer ADBreast; ovary; pancreas; prostate; melanomaTypically in adulthoodA BRCA1 or BRCA2 pathogenic variant is more likely in individuals w/:
  • Premenopausal breast cancer, especially ER/PR/HER2-negative tumors
  • Personal or family history of ovarian, pancreatic, male breast, or prostate cancer
  • No family history of adrenocortical carcinomas, CNS tumors, osteosarcomas, or soft-tissue sarcomas
CHEK2 CHEK2 cancer susceptibility (OMIM 609265)ADBreast; colorectal; prostateTypically in adulthoodCHEK2 pathogenic variants are more likely to explain personal & family histories of predominantly breast, colon, prostate, or other adult-onset cancers.
MLH1
MSH2
MSH6
PMS2
Constitutional mismatch repair deficiency (a variant of Lynch syndrome)ARColorectal; small bowel; hematologic; brainEarly childhoodCMMRD should be considered in individuals w/childhood-onset gastrointestinal cancer or polyps, malignant brain tumor, hematologic cancer, &/or café au lait macules.

AD = autosomal dominant; AR = autosomal recessive; CMMRD = constitutional mismatch repair deficiency; CNS = central nervous system; ER = estrogen receptor; MOI = mode of inheritance; PR = progesterone receptor

From: Li-Fraumeni Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.